Home > Insider Trading > Impax Laboratories Llc

Impax Laboratories Llc (IPXL)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Tesoro Corporation (TSO), Walgreens Boots Alliance Inc (WBA), and Impax Laboratories Inc (IPXL): Slate Capital's Big Payoffs For the First Quarter

David Greenspan's Slate Path Capital staged an impressive performance in the first quarter, according to our metrics, which are based on the fund's equity holdings in companies exceeding $1 billion market...

Keep Reading →

April 16th, 2015 - Hedge Funds News

Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?

To the average investor, there are many methods market participants can use to analyze publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading activity.

Keep Reading →

September 17th, 2013 - News

Amgen, Inc. (AMGN), Impax Laboratories Inc (IPXL): Keryx Biopharmaceuticals (KERX)'s Stifel Conference Presentation

There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ:KERX) had to say at this week's Stifel Nicolaus Weisel Healthcare Conference in Boston.

Keep Reading →

September 15th, 2013 - News

This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)

In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.

Keep Reading →

September 4th, 2013 - News

Hedge Funds Are Buying Impax Laboratories Inc (IPXL)

At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies. A couple of the most under-the-radar are hedge fund and insider trading interest.

Keep Reading →

September 3rd, 2013 - News

Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?

To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading interest.

Keep Reading →

August 26th, 2013 - News

Three Things You Need to Know From Keryx Biopharmaceuticals (KERX)'s Q2 Earnings

Keryx Biopharmaceuticals (NASDAQ:KERX) announced its second-quarter results before the market opened on Thursday.

Keep Reading →

August 1st, 2013 - News

GlaxoSmithKline plc (ADR) (GSK): Does Restless Legs Syndrome Really Shorten Life Span?

It may surprise you, but restless legs syndrome (RLS) affects 7% to 10% of the U.S. population, with varying degrees of severity.

Keep Reading →

June 18th, 2013 - News

Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)

In the 21st century investor’s toolkit, there are plenty of indicators market participants can use to watch the equity markets.

Keep Reading →

June 12th, 2013 - News

Neurocrine Biosciences, Inc. (NBIX): Are Hedge Funds Right About This Stock?

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds' portfolio at the end of the first quarter of 2013. NBIX has experienced an increase in hedge fund sentiment recently.

Keep Reading →

June 6th, 2013 - News